000			01841nam a22002657a 4500
005			20260507115434.0
008			260507b |||||||| |||| 00| 0 eng d
022			_a0261-1929
040			_aMMSU _cULS
210			_aATLA
222			_aAlternatives to Laboratory Animals
245			_aATLA : _bAlternatives to laboratory animals
260			_aLondon: _bSage Publications, _c2025-
300			_avolumes ; _c28 cm.
310			_aSix times a year.
362			_aVolume 53, Number 5 (September 2025- )
500			_aATLA is a peer-reviewed journal, intended to cover all aspects of the development, validation, implementation and use of alternatives to laboratory animals in biomedical research and toxicity testing. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo
505			_tCombinatorial induction with valproic acid and fibroblast growth factor-9 enhances neural differentiation and cell fate commitment in adipose tissue-derived mesenchymal stem cells (pp. 249–260) / _rLubna Khan, Nazia Ahmed, and Bushra Kiran Naeem
505			_tMesoporous bioactive glass nanoparticles exhibit intrinsic angiogenic potential in the chorioallantoic membrane assay, without the addition of exogenous cells (pp. 261–270) / _rMaximilian N. Moll, Qaisar Nawaz, and Fabian Westhauser
505			_tThe Recombinant Antibodies & Mimetics Database: Redefining the future of antibody use in science (pp. 271–280) / _rStephanie Modi
505			_tBiosensor-based approaches: Exploring hapten–protein interactions for the prediction of skin sensitisation (pp. 281–300) / _rTeh Ubaidah Noh and Nurul Izzah Khalid
650			_aBiomedical research _vPeriodicals
650			_aAnimals as alternatives in laboratoies _vPeriodicals
942			_2lcc _cSERIALS
999			_c29091 _d29091